Drug Trial Radar · NCT05439629
Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration
Last checked: Nov 19, 2026Latest source record: Dec 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
488
Actual
Start
Jul 7, 2022
Primary completion
Apr 22, 2025
Study completion Apr 22, 2025
Sponsor
- Lead sponsor
- Bio-Thera SolutionsIndustry
- Sponsor type
- Industry
- First posted
- Jun 30, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A non-inferiority design was used to conduct a randomized, double-blind, parallel-controlled multi-center study. A total of 488 subjects with neovascular (wet) age-related macular degeneration (w-AMD) were planned to be enrolled. Qualified subjects were divided into experimental group and control group in a 1:1 ratio, and stratified randomized according to the letter value of baseline period and whether the eyes had received anti-VEGF drug treatment. The experimental group received BAT5906 injection. The control group received Lucentis® treatment. Only 1 eye per subject was included in this study.
Conditions
- Neovascular (Wet) Age-related Macular Degeneration
Interventions
BAT5906 injectionDrug
4.0 mg/eye/time, 50 μl, intravitreal injection
LucentisDrug
0.5 mg/eye/time, 50 μl, intravitreal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- The change in the BCVA valueTime frame: Week 52
- The change in the BCVA valueTime frame: at weeks 12, 24, 36, and 48
- BCVA increased the proportion of subjects with >10, >15, ≥30 wordsTime frame: in the 24th and 52nd weeks
- BCVA reduced the proportion of subjects < 10, < 15 wordsTime frame: at weeks 24 and 52
- Changes in the thickness of the macular fovea (CRT).Time frame: at weeks 12, 24, 36, 48, and 52
Locations
48 sites in 1 country. Site status is shown where the registry gives one.
Affiliated Hospital of Inner Mongolia Medical University
Beijing, China
Beijing Chao Yang Hospital
Beijing, China
Beijing Hospital
Beijing, China
China-Japan Friendship Hospital
Beijing, China
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, China
Peking University People's Hospital
Beijing, China
Xiangya Hospital of Central South University
Changsha, China
The First Affiliated Hospital of Army Medical University (Southwest Hospital)
Chongqing, China
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, China
First Affiliated Hospital of Fujian Medical University
Fujian, China
First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, China
Guangzhou Aier Eye Hospital
Guangzhou, China
Sun Yat-sen Ophthalmic Center, Sun Yat-sen University
Guangzhou, China
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Guangzhou, China
Affiliated Hospital of Guizhou Medical University
Guiyang, China
Zhejiang Provincial People's Hospital
Hangzhou, China
The Second Hospital of Anhui Medical University
Hefei, China
People's Hospital of Wuhan University (Hubei Provincial People's Hospital)
Hubei, China
The First Hospital of Jilin University
Jilin City, China
Jinan Second People's Hospital
Jinan, China
The Affiliated Eye Hospital of Shandong University of Chinese Medicine
Jinan, China
Jinzhong First People's Hospital
Jinzhong, China
The First People's Hospital of Kunming
Kunming, China
Luoyang Third People's Hospital
Luoyang, China
The Affiliated Eye Hospital of Nanchang University
Nanchang, China
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Nanjing, China
Affiliated Hospital of Nantong University
Nantong, China
Ningbo Eye Hospital
Ningbo, China
Pingxiang People's Hospital
Pingxiang, China
People's Hospital of Quzhou
Quzhou, China
Huashan Hospital
Shanghai, China
Shanghai Oriental Hospital
Shanghai, China
Shanghai University of Traditional Chinese Medicine
Shanghai, China
The Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China
Shantou University-Chinese University of Hong Kong Joint Shantou International Eye Centre
Shantou, China
The Fourth People's Hospital of Shenyang
Shenyang, China
Shenzhen People's Hospital
Shenzhen, China
Second Hospital of Shanxi Medical University
Taiyuan, China
Taizhou Hospital of Zhejiang Province
Taizhou, China
Weifang Eye Hospital
Weifang, China
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.